by Dean Garrison, DC Clothesline:
The first “live” Ebola vaccines for preventative measures were given to patients at Denver Health in Colorado this past week, marking what Becker’s Hospital Review described as a “milestone movement.”
Back in 2015, the Department of Health and Human Services designated Denver Health as one of 13 Regional Emerging Special Pathogens Treatment Centers in the United States. Denver Health functions as an infectious disease training and care hub for six states in the region.
TRUTH LIVES on at https://sgtreport.tv/
Denver Health is one of the first health systems in the country to administer the injection, known as Ervebo, which was first approved by the Food and Drug Administration back in 2019 for anyone one-year-old and above.
Even though Ebola is exceptionally rare in the U.S., Big Pharma has been dead set on “vaccinating” the entire country for it. The disease is said to have a mortality rate of between 70 percent and 90 percent when left untreated, according to the Centers for Disease Control and Prevention (CDC).
“Importation of Ebola disease to the United States by an infected traveler from an outbreak area is a recognized risk with the potential for spread to other people,” the CDC says. “During the 2014-2016 Ebola disease outbreak in West Africa, 11 people were treated for [Ebola] in the U.S., and two of them died. Nine of these cases were imported into the U.S.”
The other two cases the CDC mentioned involved healthcare workers who were treating patients at the time they became infected. (Related: NIH pushing to vaccinate entire countries with Ebola vaccine.)
